{"name":"Pacific Biosciences","slug":"pacific-bio","ticker":"PACB","exchange":"NASDAQ","domain":"pacb.com","description":"Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.","hq":"Menlo Park, CA","founded":0,"employees":"485","ceo":"Christian Henry","sector":"Genomic Sequencing / Life Sciences Tools","stockPrice":1.21,"stockChange":-0.06,"stockChangePercent":-4.72,"marketCap":"$376M","metrics":{"revenue":160030000,"revenueGrowth":0.1,"grossMargin":38.3,"rdSpend":97307000,"netIncome":-546376000,"cash":275961984,"dividendYield":0,"peRatio":-2.9,"fiscalYear":"FY2017"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-27","type":"earnings","headline":"Pacific Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Pacific Biosciences reported fourth quarter and full year 2023 financial results, with revenue of $63.4 million and a net loss of $43.8 million.","drugName":"","sentiment":"neutral"},{"date":"2023-11-15","type":"deal","headline":"Pacific Biosciences Announces Collaboration with the University of California, San Diego","summary":"Pacific Biosciences announced a collaboration with the University of California, San Diego to advance the development of new genomics technologies.","drugName":"","sentiment":"positive"}],"realNews":[{"date":"2026-03-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNWXNoV2thUHlXTjl0RjdWaHJxLV9fUmF3UGJkbEpDc0JUUFhGU1ppa0t2bDM3QWtFbWZWck5lQXhFNEo1aklhVTE2TFJmbzFBLWwzYUZwRmtHUHExYjEtS1A5N2pIWW94V3AwRFdlWmZOZnZmWFFYNWV4ZGpsOG83cGhDRDhLMmtPUXJuc3h6RWdaTWJHY09KejEwV1lrLTFjV2lpTnlnYzZ6ejNObkN3N21QQ2FvenhRYVBKWg?oc=5","date":"2026-03-05","type":"pipeline","source":"Stock Titan","summary":"AI drug discovery founder from Recursion joins PacBio board - Stock Titan","headline":"AI drug discovery founder from Recursion joins PacBio board","sentiment":"neutral"},{"date":"2026-03-05","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxOUUYtYkN6TjFSTVE2Wmd3U1BEajVLRExGQncyQVhuYzE1Uk16ODVrTUFrbnRpRW9iQWZuWmpnVHdYbzl5NWtHNC1JOGRvUnR6WHZmNGczeWswajVkUHI4LTljQTBkckU5Z1NxM0ZBSDk2SjNHaEZzc0E0S2Zqcm0xYjVmN3FremRf?oc=5","date":"2026-03-04","type":"earnings","source":"Yahoo Finance","summary":"Life Sciences Tools & Services Stocks Q4 Recap: Benchmarking PacBio (NASDAQ:PACB) - Yahoo Finance","headline":"Life Sciences Tools & Services Stocks Q4 Recap: Benchmarking PacBio (NASDAQ:PACB)","sentiment":"neutral"},{"date":"2026-02-25","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-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?oc=5","date":"2026-02-14","type":"earnings","source":"simplywall.st","summary":"Pacific Biosciences Of California (PACB) Q4 Losses Highlight Ongoing Profitability Concerns Despite Revenue Base - simplywall.st","headline":"Pacific Biosciences Of California (PACB) Q4 Losses Highlight Ongoing Profitability Concerns Despite Revenue Base","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxQSzFyUkVTS3E0ek54QXNNUGtOLXViUDlIYWpJdTFfNWlPTzNQZ1ZuZG93MU9GY3dOd1R2aVRVT1FHRjRWT0d0Y09mb0ktODRtWTVNSHQtcXdRQWd2c3p3UWxXUGlfdlFNT2lpV1F1YnczcjB0bXYzQURSaEFEQTRPYUlrdWJ3b2VvZnNvZTRVTFZWdmg0NGp4MEU1T0V3WS1WQkdnalUwUUZWU0FJZHZkWmJEd0lkOFFCdHJzaDRxdjliRXA2djBJNVhSWjdfalBEXzF4NHBBVFNLS2JjLS1VWlVtYTlJamNrUEY3R0xYeDZVMVN4VDlmNnViRmVaaXNybDFaMzVRVDExRkVVek83ajBpX2NGSjg?oc=5","date":"2026-02-13","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Pacific Biosciences (PACB) - The Globe and Mail","headline":"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Pacific Biosciences (PACB)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-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?oc=5","date":"2026-01-21","type":"pipeline","source":"simplywall.st","summary":"Pacific Biosciences of California, Inc. (NASDAQ:PACB) Stocks Shoot Up 28% But Its P/S Still Looks Reasonable - simplywall.st","headline":"Pacific Biosciences of California, Inc. (NASDAQ:PACB) Stocks Shoot Up 28% But Its P/S Still Looks Reasonable","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-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?oc=5","date":"2026-01-08","type":"pipeline","source":"simplywall.st","summary":"Pacific Biosciences (PACB) Is Up 13.9% After Revio, Vega and SPRQ-Nx Drive New Customer Growth - simplywall.st","headline":"Pacific Biosciences (PACB) Is Up 13.9% After Revio, Vega and SPRQ-Nx Drive New Customer Growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxPc2VwNWI1YW82Y2RoQ1d2VDhfM0I2OE1hS3F0SDJVU3d1TmZ3RHBIWHhJcUdQSlFZdE1Ld18tQVh2dU5yQTFHeC1RZ1k1Ui1uNXNGTl81ZWNSUGJGeTJkQXJyM3pqcmYzcnhITHZ5TTJlR0FRc3MxUVdnNEo2Q0NXc19sSXlHemVMUUZWRDdZYjIyX3BGdjBtb3Rmb3RyNGs4aC1LSlUzYVl2QW5FeUhzdU9mejc5U1dNUy1heEZWNHRBRmN6enlfTGg0T2d1V2NWeFVlTFJCSERTQm1UNTNralIxM3dGZjRCUnpYd0ppYXNCUk92ampGLUQzUjPSAYICQVVfeXFMTnQ3N1VsQm90MXNKX2E4VEFjeC1tU2k4M3J3ZlkzdmtvVFpReWt4TlowbjdOclctcjVSbmlHbTBvWUhWVlE5UWxRdjdlRElqN3QyaEJkRnBpSzloQ3RQaTN3Zkk3ZXRYZE1WV2pGNlRwVk1YUVIxUm14c182aVFudXlJcjM1bHpzNFQxWUhVX05PYkx5OGs3aHRNZk5hME5DNHlsTXRBY1pNUjBVUUlzek4xaWZNb2d4SGtDXzc1RmJmVldRU1V5RDRFWGRkWGlkOU9jbTdZNjJYS1piZlpQVlVmRFBKV2lkR2liMm1Lb1pFN2dHREp5bDFsQ202VlBVbXVn?oc=5","date":"2026-01-06","type":"pipeline","source":"simplywall.st","summary":"We Think Pacific Biosciences of California (NASDAQ:PACB) Has A Fair Chunk Of Debt - simplywall.st","headline":"We Think Pacific Biosciences of California (NASDAQ:PACB) Has A Fair Chunk Of Debt","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPYXBvNi1SN2s2STNVaUFaOFBiMGRiR3BwTW1hYU4zdW1NekFHNEVqcE96VWtGUTNOZ2ZrY0xvQUVFSm9FMlZ2Z0RuaXh2NXhpbWtka2dpYXhvUFZrN1VmQXNfMXVtRW02Yl9hclNLaG5JRXo0ZDVRWlJkcXVQaFN0b29uUUVSRzdKUDd5Wm81NVhUM0NGV3htMDU4WHhPaE5hbVMxdEEtVC1JQW5rNkNHLTlB?oc=5","date":"2025-12-31","type":"pipeline","source":"FinancialContent","summary":"Why Is PacBio (PACB) Stock Soaring Today - FinancialContent","headline":"Why Is PacBio (PACB) Stock Soaring Today","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNaHZlek1TcXlsUXBnZk1LbklMMDd0MnFnV0lXR282V3RVQUxkdjJ1cW84a04xYy1NMDVwQmlDelo0UjVEU2xON1FHenZ6c1BVdTJ1Zm1hS2lnLVV4SGpZOEltZGVSekNxeTVNVWRBWDNMaUdxNndnT2JRYjRpcU9wQ2I2QlRObEJyaFJrbHVyV1RoQklJREp2cXpDUlMxNFlYM243YlBMMA?oc=5","date":"2025-12-18","type":"pipeline","source":"Seeking Alpha","summary":"Pacific Biosciences: Longer Reads, But Shorter Patience (Downgrade) (PACB) - Seeking Alpha","headline":"Pacific Biosciences: Longer Reads, But Shorter Patience (Downgrade) (PACB)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9vOWdnVkZiRjJHNGZVLWoyd1ZxclB5c0RKcVJDdTFUd0hIUlF6MGdOUlVGb2l3eW1Jb1h4WXd1UkVSd1g3Zm8xRmM1bHJBOU5xRnh0QnJ6OWhBN1RXY29UVmpTUEhBYUNORk5zbmVMY2FLTmY2dnJtM3M3d0I?oc=5","date":"2025-11-06","type":"earnings","source":"Yahoo Finance","summary":"PACB Stock Down Despite Q3 Earnings Beat Estimates, Revenues Down Y/Y - Yahoo Finance","headline":"PACB Stock Down Despite Q3 Earnings Beat Estimates, Revenues Down Y/Y","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOYS0tMm5CeFBtMUFOT0dqejRfT3ZyR0RxVFVVaFFNY3pfTnFMWklTT1Vaa04taGVpdlhEYlQ5bzl2X2NDdi1CaXRNRHhTX29vVFUxaFY0ejUwekl3NG9BXzFrTjl1bmtCVHpmMVhZTlZiak1lVDdYTFFkc0h6ZS1UZXVmdkpLbl9XT2d4ZTdoSHljdDZTa3ViNXhwdC0tcGVfQ2hwZk1KUjE3NGpBTzhuX2xmT3dkdHRsTjB4QmR3bkU?oc=5","date":"2025-10-10","type":"pipeline","source":"TradingView","summary":"Here's Why You Should Retain PacBio Stock in Your Portfolio for Now - TradingView","headline":"Here's Why You Should Retain PacBio Stock in Your Portfolio for Now","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQUlRpX0FTRl8zMVBrZVFkMXhYSTNjRTdJOE9MRUdRek9OTklEZUpPdjViREMtX2JmbFUtQTdrSDdKb1EzSmJ2TG5zNm5XLTRTeDh1eEFEb2FfUWF2eGEydTluRGUyY3FJaXJyNzgwOWZJS1JjSUJub0xXdEh5S21rOVh2Y25nSERzSGxDLWswR1JhckdOSUw1Y2c3dkl1cW1fdkpKdWptZjZGdE4tNWdEdmx3?oc=5","date":"2024-07-19","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"StockWatch: PacBio Scores Biggest One-Day Gain Since 2018, but Momentum Fades - Genetic Engineering and Biotechnology News","headline":"StockWatch: PacBio Scores Biggest One-Day Gain Since 2018, but Momentum Fades","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Illumina","Thermo Fisher Scientific","Oxford Nanopore Technologies"],"therapeuticFocus":["Genomic Sequencing","Synthetic Biology"],"financials":{"source":"sec_edgar+yahoo","revenue":93468000,"revenuePeriod":"2017-12-31","revenueHistory":[{"value":93468000,"period":"2017-12-31"},{"value":24935000,"period":"2017-12-31"},{"value":23545000,"period":"2017-09-30"},{"value":20073000,"period":"2017-06-30"},{"value":24915000,"period":"2017-03-31"}],"grossProfit":45780000,"grossProfitHistory":[{"period":"2025-12-31","value":45780000},{"period":"2024-12-31","value":37282000},{"period":"2023-12-31","value":52780000},{"period":"2022-12-31","value":49035000}],"rdSpend":97307000,"rdSpendHistory":[{"period":"2025-12-31","value":97307000},{"period":"2024-12-31","value":134922000},{"period":"2023-12-31","value":187170000},{"period":"2022-12-31","value":193000000}],"sgaSpend":141493000,"operatingIncome":-557561000,"operatingIncomeHistory":[{"period":"2025-12-31","value":-557561000},{"period":"2024-12-31","value":-290663000},{"period":"2023-12-31","value":-310365000},{"period":"2022-12-31","value":-304819000}],"netIncome":-546376000,"netIncomeHistory":[{"period":"2025-12-31","value":-546376000},{"period":"2024-12-31","value":-309851000},{"period":"2023-12-31","value":-306735000},{"period":"2022-12-31","value":-314248000}],"eps":-1.82,"epsHistory":[{"period":"2025-12-31","value":-1.82},{"period":"2024-12-31","value":-1.58},{"period":"2023-12-31","value":-1.21},{"period":"2022-12-31","value":-1.4}],"cash":63707000,"cashHistory":[{"period":"2025-12-31","value":63707000},{"period":"2024-12-31","value":55370000},{"period":"2023-12-31","value":179911000},{"period":"2022-12-31","value":325089000}],"totalAssets":784083000,"totalLiabilities":778734000,"totalDebt":702422000,"equity":5349000,"operatingCashflow":-111209000,"operatingCashflowHistory":[{"period":"2025-12-31","value":-111209000},{"period":"2024-12-31","value":-206058000},{"period":"2023-12-31","value":-259173000},{"period":"2022-12-31","value":-263211000}],"capex":-7714000,"capexHistory":[{"period":"2025-12-31","value":-7714000},{"period":"2024-12-31","value":-6188000},{"period":"2023-12-31","value":-8843000},{"period":"2022-12-31","value":-16929000}],"freeCashflow":-118923000,"dividendsPaid":null,"buybacks":null,"employees":485,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":34051000,"ebit":-38429000,"ebitda":-33780000,"period":"2025-12-31","revenue":44645000,"epsBasic":-0.13,"netIncome":-40371000,"rdExpense":22879000,"epsDiluted":-0.13,"grossProfit":16566000,"operatingIncome":-41197000},{"sga":31099000,"ebit":-35878000,"ebitda":-31476000,"period":"2025-09-30","revenue":38441000,"epsBasic":-0.13,"netIncome":-38000000,"rdExpense":22846000,"epsDiluted":-0.13,"grossProfit":15901000,"operatingIncome":-38877000},{"sga":36175000,"ebit":-40157000,"ebitda":-35575000,"period":"2025-06-30","revenue":39766000,"epsBasic":-0.14,"netIncome":-41930000,"rdExpense":22529000,"epsDiluted":-0.14,"grossProfit":14684000,"operatingIncome":-44853000},{"sga":40168000,"ebit":-424640000,"ebitda":-51861000,"period":"2025-03-31","revenue":37153000,"epsBasic":-1.44,"netIncome":-426075000,"rdExpense":29053000,"epsDiluted":-1.44,"grossProfit":-1371000,"operatingIncome":-432634000},{"sga":41641000,"ebit":5444000,"ebitda":16393000,"period":"2024-12-31","revenue":39224000,"epsBasic":0.01,"netIncome":2371000,"rdExpense":27466000,"epsDiluted":-0.49,"grossProfit":10058000,"operatingIncome":-63678000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":1.21,"previousClose":1.27,"fiftyTwoWeekHigh":2.73,"fiftyTwoWeekLow":0.85,"fiftyTwoWeekRange":"0.85 - 2.73","fiftyDayAverage":1.46,"twoHundredDayAverage":1.68,"beta":2.4,"enterpriseValue":824890112,"forwardPE":-2.9,"priceToBook":151.25,"priceToSales":2.35,"enterpriseToRevenue":5.16,"enterpriseToEbitda":-5.76,"pegRatio":0,"ebitda":-143146000,"ebitdaMargin":-89.4,"freeCashflow":-48237124,"operatingCashflow":-111844000,"totalDebt":706387968,"debtToEquity":29855.8,"currentRatio":5.65,"returnOnAssets":-12,"returnOnEquity":-273.6,"analystRating":"2.3 - Buy","recommendationKey":"buy","numberOfAnalysts":5,"targetMeanPrice":2.5,"targetHighPrice":3,"targetLowPrice":1.5,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":8.8,"institutionHeldPercent":56.4,"sharesOutstanding":310601688,"floatShares":302349001,"sharesShort":47090593,"shortRatio":7.3,"shortPercentOfFloat":15.2,"epsTrailing":-0.41,"epsForward":-0.41,"revenuePerShare":0.53,"bookValue":0.01,"officers":[{"age":57,"name":"Mr. Christian O.  Henry M.B.A.","title":"President, CEO & Director"},{"age":55,"name":"Mr. James R. Gibson II","title":"CFO & Principal Accounting Officer"},{"age":52,"name":"Mr. Mark  Van Oene Ph.D.","title":"Chief Operating Officer"},{"age":57,"name":"Dr. Stephen  Turner Ph.D.","title":"Co-Founder"},{"age":null,"name":"Dr. Brett  Atkins J.D., Ph.D.","title":"General Counsel & Corporate Secretary"},{"age":null,"name":"Ms. Natalie  Welch","title":"Chief People Officer"}],"industry":"Medical Devices","irWebsite":"","website":"https://www.pacb.com","phone":"650 521 8000"}}